| Literature DB >> 23638092 |
Pengfei Lin1, Xiangli Lan, Fenglei Chen, Yanzhou Yang, Yaping Jin, Aihua Wang.
Abstract
The study of uterine gene expression patterns is valuable for understanding the biological and molecular mechanisms that occur during embryo implantation. Real-time quantitative RT-PCR (qRT-PCR) is an extremely sensitive technique that allows for the precise quantification of mRNA abundance; however, selecting stable reference genes suitable for the normalization of qRT-PCR data is required to avoid the misinterpretation of experimental results and erroneous analyses. This study employs several mouse models, including an early pregnancy, a pseudopregnancy, a delayed implantation and activation, an artificial decidualization and a hormonal treatment model; ten candidate reference genes (PPIA, RPLP0, HPRT1, GAPDH, ACTB, TBP, B2M, 18S, UBC and TUBA) that are found in uterine tissues were assessed for their suitability as internal controls for relative qRT-PCR quantification. GeNorm(PLUS), NormFinder, and BestKeeper were used to evaluate these candidate reference genes, and all of these methods identified RPLP0 and GAPDH as the most stable candidates and B2M and 18S as the least stable candidates. However, when the different models were analyzed separately, the reference genes exhibited some variation in their expression levels.Entities:
Mesh:
Year: 2013 PMID: 23638092 PMCID: PMC3634797 DOI: 10.1371/journal.pone.0062462
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of candidate reference genes used in this study.
| Gene symbol | Gene name | Gene function |
| PPIA | Peptidylprolyl isomerase A | Catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerates the folding of proteins. |
| RPLP0 | Ribosomal protein, large, P0 | Structural constituent of ribosome. |
| HPRT1 | Hypoxanthine-guanine phosphoribosyltransferase 1 | Purine synthesis in salvage pathway. |
| GAPDH | Glyceraldehydes-3-phosphate dehydrogenase | Glycolytic enzyme. |
| ACTB | Actin, beta | Formation of major component of the cytoskeleton. |
| TBP | TATA box binding protein | Composed of transcription factor IID with TBP-associated factors. |
| B2M | Beta-2-microglobulin | Major histocompatibility complex. |
| 18S | Ribosomal protein 18s | Central component of the ribosome. Provides a mechanism for decoding mRNA into amino acids. |
| UBC | Ubiquitin C | Possible involvement in protein catabolism. |
| TUBA | Tubulin α-1 | Microtubules of the eukaryotic cytoskeleton. |
Primer information for qRT-PCR amplification.
| Gene symbol | Accession number | Primer sequence (5′ to 3′) | Amplicon length (bp) | PCREfficiency (%) |
| PPIA | NM_008907 |
| 110 | 95.6 |
| RPLP0 | NM_007475 |
| 85 | 103.5 |
| HPRT1 | NM_013556 |
| 142 | 105.6 |
| GAPDH | NM_008084 |
| 186 | 101.7 |
| ACTB | NM_007393 |
| 148 | 104.9 |
| TBP | NM_013684 |
| 107 | 101.8 |
| B2M | NM_009735 |
| 193 | 96.7 |
| 18S | NR_003278 |
| 110 | 105 |
| UBC | XM_001471699 |
| 97 | 103.3 |
| TUBA | NM_011653 |
| 218 | 102.7 |
Figure 1Range of Ct values for the candidate RGs obtained from all cDNA samples.
Each box corresponds to 18S, ACTB, B2M, GAPDH, PPIA, HPRT1, RPLP0, TBP, TUBA and UBC and indicates the 25% and 75% percentiles. Whiskers represent the maximum and minimum values. The median is depicted as a line across the box.
Figure 2GeNorm analysis of the expression stability of the 10 RGs.
(A–F) Average expression stability values (M) and ranking of the candidate RGs as calculated by geNorm software. Lower M values indicate more stable expression. (a–f) Determination of the optimal number of RGs for normalization by pairwise variation (V) as assessed by geNorm. According to the algorithm and software instructions, a cut-off V value of 0.15 was used.
Ranking of candidate reference genes in order of their expression stability as calculated by NormFinder.
| Gene | Experimental models | |||||
| All | Early Pregnancy | Pseudopregnancy | Delayed and activatedimplantation | Artificial decidualization | Hormonal treatments | |
| PPIA | 0.054 | 0.041 |
|
| 0.022 |
|
| RPLP0 |
|
|
|
|
|
|
| ACTB | 0.061 | 0.047 | 0.030 | 0.026 | 0.022 | 0.046 |
| GAPDH |
|
| 0.032 | 0.027 |
| 0.038 |
| UBC | 0.099 | 0.055 | 0.034 | 0.033 | 0.052 | 0.030 |
| TBP | 0.197 | 0.034 | 0.037 | 0.034 | 0.044 | 0.071 |
| HPRT1 | 0.098 | 0.034 | 0.042 | 0.037 | 0.073 | 0.050 |
| TUBA | 0.110 | 0.050 | 0.044 | 0.045 | 0.040 | 0.053 |
| 18S | 0.162 | 0.064 | 0.047 | 0.059 |
| 0.064 |
| B2M |
|
|
|
| 0.068 |
|
Note: Data were presented as expression stability value (M value) as calculated by NormFinder. Lower average expression stability (M value) indicates more stable expression. The values in bold refer to the most stable genes, and the values in bold italic refer to the least stable genes.
Ranking of candidate reference genes in order of their expression stability as calculated by BestKeeper.
| Gene | Experimental models | |||||
| All | Early Pregnancy | Pseudopregnancy | Delayed and activated implantation | Artificialdecidualization | Hormonal treatments | |
| RPLP0 |
|
|
|
|
|
|
| UBC | 1.76±0.45 | 2.41±0.90 | 1.19±0.24 | 1.77±0.41 | 1.17±0.30 | 1.45±0.51 |
| TUBA | 1.86±0.72 | 1.43±0.80 | 2.16±0.87 | 1.34±0.62 | 2.15±0.83 | 2.52±0.72 |
| PPIA | 1.48±0.56 |
|
| 1.44±0.32 |
| 1.21±0.43 |
| ACTB | 1.48±0.91 | 1.98±0.48 | 1.73±0.61 |
| 1.62±0.19 | 1.30±0.44 |
| GAPDH |
| 1.17±0.27 | 0.95±0.81 | 1.25±0.22 | 1.06±0.82 |
|
| HPRT1 | 1.81±0.64 | 1.19±0.76 | 2.23±1.07 | 2.13±0.69 | 2.09±0.53 | 2.82±0.58 |
| TBP | 2.88±0.94 | 2.24±0.46 | 1.76±0.79 | 2.65±0.53 | 2.21±0.79 | 2.68±0.89 |
| B2M |
|
|
| 3.85±0.93 | 2.62±0.76 |
|
| 18S | 2.78±0.99 | 2.46±0.95 | 1.85±0.26 |
|
| 2.67±0.59 |
Note: Data were presented as coefficient of variance (CV) ± standard deviation (SD). Reference genes are identified as the most stable genes (those with the lowest CV ± SD value). The values in bold refer to the most stable genes, and the values in bold italic refer to the least stable genes.
Comparison of reference gene expression as determined by three distinct algorithms.
| Experimental models | The most stable genes | The least stable genes | ||||
| GeNorm | NormFinder | BestKeeper | GeNorm | NormFinder | BestKeeper | |
| All | RPLP0 & GAPDH | GAPDH & RPLP0 | GAPDH & RPLP0 | B2M | B2M | B2M |
| Early Pregnancy | RPLP0 & GAPDH | RPLP0 & GAPDH | RPLP0 & PPIA | B2M | B2M | B2M |
| Pseudopregnancy | GAPDH & RPLP0 | RPLP0 & PPIA | RPLP0 & PPIA | B2M | B2M | B2M |
| Delayed and activatedimplantation | RPLP0 & GAPDH | PPIA & RPLP0 | RPLP0 & ACTB | 18S | B2M | 18S |
| Artificial decidualization | PPIA & RPLP0 | GAPDH & RPLP0 | PPIA & RPLP0 | 18S | 18S | 18S |
| Hormonal treatments | PPIA & GAPDH | RPLP0 & PPIA | GAPDH & RPLP0 | B2M | B2M | B2M |